Clinical trial
Safety and Efficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac Surgery for Coronary Artery Disease Patients Treated With Oral Antiplatelet Agents
NCT04675801 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac Surgery for Coronary Artery Disease Patients Treated With Oral Antiplatelet Agents
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 2, 2021
- Completion date
- June 30, 2023
- Enrollment
- 950 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.